Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ElleS vs REMEVi

ElleS
Graded #424

Lower grade

vs+14.400000000000006
REMEVi
Graded #105

Higher grade

The verdict

REMEVi takes it — 70.4/100 to 56/100.

REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueREMEVi +9
45
54
Dose & formulationREMEVi +13
51
64
Clinical oversightREMEVi +8
78
86
Labs & monitoringREMEVi +4
61
65
FulfillmentREMEVi +29
68
97
Contract termsREMEVi +49
20
69
ElleS · left barREMEVi · right bar

The numbers

MetricElleSREMEVi
WeighScore56/10070.4/100
GradeCC
Scorecard rank#424#105
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$269/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
ElleS

Graded #424 · C

Strengths

  • Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
  • Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
  • Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
  • Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)

Where it loses points

  • Pricing not shown publicly — products and costs appear only after the intake flow
  • Sold as 3- and 6-month packages rather than simple monthly plans
  • Compounding pharmacy partner not named ('made in licensed US facilities')
  • Not LegitScript-certified (no certification displayed)
REMEVi

Graded #105 · C

Strengths

  • The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
  • Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
  • LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
  • Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)

Where it loses points

  • Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
  • The specific compounding pharmacy is not named (described as 'NPI-verified')
  • A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard